GeneDx is the genetic testing platform that 80% of pediatric and genetic providers choose, yet it flies under the radar in the consumer tech world. While competitors chase headlines, this $402M revenue company is quietly building the infrastructure for rare disease diagnosis.

"GeneDx isn't selling tests—they're selling certainty in the most uncertain moments of a family's life."

What makes GeneDx unique is their positioning as the 'preferred' rather than the 'first.' In a field crowded with direct-to-consumer genetic tests, they've deliberately avoided the consumer hype cycle. Their focus is purely on clinical utility: faster turnaround, more precise panels, and actionable results for complex conditions. This clinical-first approach has created a defensive moat that consumer brands can't easily replicate.

• Dominates 80% of provider preference in genetic testing
• Generates $378K revenue per employee (exceptional for healthcare)
• 50% direct traffic indicates strong brand recall and loyalty
• Focuses exclusively on rare/complex conditions—not consumer wellness
• Built a 1,000+ person organization without fanfare or hype